Literature DB >> 16557714

Amantadine therapy of epidemic influenza a(2) (Hong Kong).

V Knight1, D Fedson, J Baldini, R G Douglas, R B Couch.   

Abstract

In a double-blind comparison of the therapeutic effect of amantadine in a natural outbreak of Hong Kong influenza in January 1969 near Houston, Texas, the decrease in titers of virus in throat swabs from 12 treated patients during the first 10 hr of treatment was appreciably greater than similar titers of virus from 16 untreated patients (P = 0.06). The titer of shed virus decreased significantly more rapidly (P < 0.05) among amantadine-treated patients ill more than 48 hr before treatment than among five control patients who had been ill more than 48 hr. Cough, sore throat, and nasal obstruction cleared more rapidly in treated patients (P < 0.05), and decline of fever in 6 treated patients sick for less than 48 hr before treatment was more rapid than among 13 untreated patients who had been ill for less than 48 hr. These findings are considered to be consistent with a limited therapeutic effect of the drug.

Entities:  

Year:  1970        PMID: 16557714      PMCID: PMC415878          DOI: 10.1128/iai.1.2.200-204.1970

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  6 in total

1.  EXPERIMENTAL INFECTION OF HUMAN VOLUNTEERS WITH EQUINE INFLUENZA VIRUS.

Authors:  J A KASEL; R H ALFORD; V KNIGHT; G H WADDELL; M M SIGEL
Journal:  Nature       Date:  1965-04-03       Impact factor: 49.962

2.  Newly recognized myxoviruses from children with respiratory disease.

Authors:  R M CHANOCK; R H PARROTT; K COOK; B E ANDREWS; J A BELL; T REICHELDERFER; A Z KAPIKIAN; F M MASTROTA; R J HUEBNER
Journal:  N Engl J Med       Date:  1958-01-30       Impact factor: 91.245

3.  Protective effect of 1-adamantanamine hydrochloride on influenza A2 infections in the family environment: a controlled double-blind study.

Authors:  A W Galbraith; J S Oxford; G C Schild; G I Watson
Journal:  Lancet       Date:  1969-11-15       Impact factor: 79.321

4.  Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occurring influenza A2 respiratory illness in man.

Authors:  W L Wingfield; D Pollack; R R Grunert
Journal:  N Engl J Med       Date:  1969-09-11       Impact factor: 91.245

5.  Treatment of influenza. The therapeutic efficacy of rimantadine HC1 in a naturally occurring influenza A2 outbreak.

Authors:  S Rabinovich; J T Baldini; R Bannister
Journal:  Am J Med Sci       Date:  1969-05       Impact factor: 2.378

6.  Influenza infections of mice. I. Curative activity of amantadine HCl.

Authors:  J W McGahen; C E Hoffmann
Journal:  Proc Soc Exp Biol Med       Date:  1968-12
  6 in total
  23 in total

Review 1.  Perspectives on antiviral use during pandemic influenza.

Authors:  F G Hayden
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2001-12-29       Impact factor: 6.237

Review 2.  Amantadine and rimantadine for influenza A in adults.

Authors:  T Jefferson; V Demicheli; C Di Pietrantonj; D Rivetti
Journal:  Cochrane Database Syst Rev       Date:  2006-04-19

Review 3.  Antiviral agents: action and clinical use.

Authors:  T W Chang; D R Snydman
Journal:  Drugs       Date:  1979-11       Impact factor: 9.546

Review 4.  Antiviral agents: an update--Part I.

Authors:  S Bogger-Goren; P L Ogra
Journal:  Indian J Pediatr       Date:  1980 Sep-Oct       Impact factor: 1.967

5.  Factors influencing quantitative isolation of varicella-zoster virus.

Authors:  M J Levin; S Leventhal; H A Masters
Journal:  J Clin Microbiol       Date:  1984-06       Impact factor: 5.948

6.  Serological responses and results of natural infectious challenge of recipients of zonal ultracentrifuged influenza A2-Aichi-2-68 vaccine.

Authors:  V Knight; R B Couch; R G Douglas; N M Tauraso
Journal:  Bull World Health Organ       Date:  1971       Impact factor: 9.408

7.  Fifty Years of Influenza A(H3N2) Following the Pandemic of 1968.

Authors:  Barbara J Jester; Timothy M Uyeki; Daniel B Jernigan
Journal:  Am J Public Health       Date:  2020-05       Impact factor: 9.308

8.  Serological evidence of recent influenza virus A (H 3 N 2) infections in forensic cases of the sudden infant death syndrome (SIDS).

Authors:  P Zink; J Drescher; W Verhagen; J Flik; H Milbradt
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

9.  Recent influenza virus A infections in forensic cases of sudden unexplained death.

Authors:  J Drescher; P Zink; W Verhagen; J Flik; H Milbradt
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

10.  Comparative activity of amantadine and ribavirin against influenza virus in vitro: possible clinical relevance.

Authors:  M J Browne; M Y Moss; M R Boyd
Journal:  Antimicrob Agents Chemother       Date:  1983-03       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.